You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Armistice Capital | 0 | 1,852,000 | 0 | 1,852,000 | 1,852,000 | 9.96% |
Armistice Capital Master Fund Ltd | 0 | 1,852,000 | 0 | 1,852,000 | 1,852,000 | 9.96% |
Steven Boyd | 0 | 1,852,000 | 0 | 1,852,000 | 1,852,000 | 9.96% |
Follow Steven Boyd's Armistice Capital
Page 1 of 10 – SEC Filing
Novelion Therapeutics Inc. |
(Name of Issuer) |
Common Stock |
(Title of Class of Securities) |
67001K202 |
(CUSIP Number) |
December 31, 2016 |
(Date of Event Which Requires Filing of this Statement) |